» Articles » PMID: 33809057

Breast Tumor Characterization Using [F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics

Abstract

: This study investigated the performance of ensemble learning holomic models for the detection of breast cancer, receptor status, proliferation rate, and molecular subtypes from [F]FDG-PET/CT images with and without incorporating data pre-processing algorithms. Additionally, machine learning (ML) models were compared with conventional data analysis using standard uptake value lesion classification. : A cohort of 170 patients with 173 breast cancer tumors (132 malignant, 38 benign) was examined with [F]FDG-PET/CT. Breast tumors were segmented and radiomic features were extracted following the imaging biomarker standardization initiative (IBSI) guidelines combined with optimized feature extraction. Ensemble learning including five supervised ML algorithms was utilized in a 100-fold Monte Carlo (MC) cross-validation scheme. Data pre-processing methods were incorporated prior to machine learning, including outlier and borderline noisy sample detection, feature selection, and class imbalance correction. Feature importance in each model was assessed by calculating feature occurrence by the R-squared method across MC folds. : Cross validation demonstrated high performance of the cancer detection model (80% sensitivity, 78% specificity, 80% accuracy, 0.81 area under the curve (AUC)), and of the triple negative tumor identification model (85% sensitivity, 78% specificity, 82% accuracy, 0.82 AUC). The individual receptor status and luminal A/B subtype models yielded low performance (0.46-0.68 AUC). SUV model yielded 0.76 AUC in cancer detection and 0.70 AUC in predicting triple negative subtype. : Predictive models based on [F]FDG-PET/CT images in combination with advanced data pre-processing steps aid in breast cancer diagnosis and in ML-based prediction of the aggressive triple negative breast cancer subtype.

Citing Articles

Clinician-driven automated data preprocessing in nuclear medicine AI environments.

Krajnc D, Spielvogel C, Ecsedi B, Ritter Z, Alizadeh H, Hacker M Eur J Nucl Med Mol Imaging. 2025; .

PMID: 40053121 DOI: 10.1007/s00259-025-07183-5.


Harnessing Artificial Intelligence to Enhance Global Breast Cancer Care: A Scoping Review of Applications, Outcomes, and Challenges.

Chia J, He G, Ngiam K, Hartman M, Ng Q, Goh S Cancers (Basel). 2025; 17(2).

PMID: 39857979 PMC: 11764353. DOI: 10.3390/cancers17020197.


Magnetic Resonance Image Radiomic Reproducibility: The Impact of Preprocessing on Extracted Features from Gross and High-Risk Clinical Tumor Volumes in Cervical Cancer Patients before Brachytherapy.

Sadeghi M, Abdalvand N, Mahdavi S, Abdollahi H, Qasempour Y, Mohammadian F J Med Signals Sens. 2024; 14:23.

PMID: 39234589 PMC: 11373798. DOI: 10.4103/jmss.jmss_57_22.


Error mitigation enables PET radiomic cancer characterization on quantum computers.

Moradi S, Spielvogel C, Krajnc D, Brandner C, Hillmich S, Wille R Eur J Nucl Med Mol Imaging. 2023; 50(13):3826-3837.

PMID: 37540237 PMC: 10611844. DOI: 10.1007/s00259-023-06362-6.


Clinical application of F-fluorodeoxyglucose positron emission tomography/computed tomography radiomics-based machine learning analyses in the field of oncology.

Nakajo M, Jinguji M, Ito S, Tani A, Hirahara M, Yoshiura T Jpn J Radiol. 2023; 42(1):28-55.

PMID: 37526865 PMC: 10764437. DOI: 10.1007/s11604-023-01476-1.


References
1.
Lacroix M, Frouin F, Dirand A, Nioche C, Orlhac F, Bernaudin J . Correction for Magnetic Field Inhomogeneities and Normalization of Voxel Values Are Needed to Better Reveal the Potential of MR Radiomic Features in Lung Cancer. Front Oncol. 2020; 10:43. PMC: 7006432. DOI: 10.3389/fonc.2020.00043. View

2.
Loughran C, Keeling C . Seeding of tumour cells following breast biopsy: a literature review. Br J Radiol. 2011; 84(1006):869-74. PMC: 3473763. DOI: 10.1259/bjr/77245199. View

3.
Leithner D, Mayerhoefer M, Martinez D, Jochelson M, Morris E, Thakur S . Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics. J Clin Med. 2020; 9(6). PMC: 7356091. DOI: 10.3390/jcm9061853. View

4.
Castiglioni I, Gallivanone F, Soda P, Avanzo M, Stancanello J, Aiello M . AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomics. Eur J Nucl Med Mol Imaging. 2019; 46(13):2673-2699. DOI: 10.1007/s00259-019-04414-4. View

5.
Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L . European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. Ann Oncol. 2007; 19(4):614-22. DOI: 10.1093/annonc/mdm481. View